Xizhi Wen

The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression

Wen Pan, Shu Zhu, Kun Qu et al. · Immunity · 2017 · 179 citations · Full text

Tumor Biology, Tumor-infiltrating Myeloid Cells, Medicine +9

Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

Jingjing He, Xinxin Xiong, Han Yang et al. · Cell Research · 2022 · 162 citations · Full text

Immunotherapy Response, Tumor Immunology, Cancer Immunosurveillance +15

A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)

Lu Si, Xiaoshi Zhang, Yongqian Shu et al. · Translational Oncology · 2019 · 133 citations · Full text

Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas

Haitao Niu, Qi‐Ming Zhou, Fang Wang et al. · Pigment Cell & Melanoma Research · 2013 · 45 citations

Lymphoid Neoplasia, Braf Mutation, Medicine +15

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Qiuzhong Pan, Desheng Weng, Jiayong Liu et al. · Cell Reports Medicine · 2023 · 44 citations · Full text